Breast carcinoma with noninflammatory skin involvement (T4b): Time to abandon an historic relic from the TNM classification

Cancer

Volumn 104, Issue 9, 2005, Pages 1862-1870

  Guth, Uwe ^a   Wight, Edward ^a   Schotzau, Andreas ^b   Langer, Igor ^a   Dieterich, Holger ^c   Rochlitz, Christoph ^a   Herberich, Linda ^a   Holzgreve, Wolfgang ^a   Singer, Gad ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b JPS Institute for Biomathematics   (Switzerland)

^c Women's Hospital   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Breast carcinoma; Prognostic factors; Skin involvement; TNM classification

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EDEMA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SKIN DISEASES; SKIN ULCER; SURVIVAL ANALYSIS;

EID: 27244454687     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21394     Document Type: Article

References (30)

1. Sugg S, Donegan W. Staging and prognosis. In: Donegan W, Spratt J, editors. Cancer of the breast, 5th ed. Philadelphia: Saunders, 2002:477-506.
2. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 6th ed. New York: John Wiley & Sons, 2002.
3. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002.
4. Guth U, Moch H, Herberich L, Holzgreve W. Noninflammatory breast carcinoma with skin involvement. Cancer. 2004;100:470-478.
5. Shen J, Valero V, Buchholz TA, et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol. 2004;11:854-860.
6. Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M. D. Anderson Cancer Center experience. J Clin Oncol. 2001;19:628-633.
7. Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol. 2004;22:4067-4074.
8. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181-187.
9. Chang J, Hilsenbeck S. Prognostic and predictive markers. In: Harris J, Lippman M, Morrow M, Osborne K, editors. Diseases of the breast, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004:675-696.
10. Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH, editors. TNM supplement. A commentary on uniform use, 3rd ed. New York: Wiley-Liss, 2004.
11. El-Tamer M, Hussain S, Weedon J, et al. Prognoses of T4 breast cancer subsets. Ann Surg Oncol. 2002;9:340-345.
12. Poole GV, Thigpen JT, Vance RB, Barber WH. Management of women who present with T4 breast cancer. Am Surg. 2004;70:662-666; discussion, 666-667.
13. Price A, Kerr GR, Rodger A. Primary radiotherapy for T4 breast cancer. Clin Oncol (R Coll Radiol). 1992;4:217-221.
14. Rao DV, Bedwinek J, Perez C, Lee J, Fineberg B. Prognostic indicators in Stage III and localized Stage IV breast cancer. Cancer. 1982;50:2037-2043.
15. Rubens RD, Armitage P, Winter PJ, Tong D, Hayward JL. Prognosis in inoperable Stage III carcinoma of the breast. Eur J Cancer. 1977;13:805-811.
16. Sutherland CM, Mather FJ. Long-term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment). Cancer. 1985;55:1389-1397.
17. Valagussa P, Zambetti M, Bonadonna G, Zucali R, Mezzanotte G, Veronesi U. Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat. 1990;15:137-147.
18. Wieland AW, Louwman MW, Voogd AC, van Beek MW, Vreugdenhil G, Roumen RM. Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J. 2004;10:123-128.
19. Yildirim E, Semerci E, Berberoglu U. The analysis of prognostic factors in Stage III-B non-inflammatory breast cancer. Eur J Surg Oncol. 2000;26:34-38.
20. Zucali R, Kenda R. Small size T4 breast cancer. Natural history and prognosis. Tumori. 1981;67:225-230.
21. Touboul E, Lefranc JP, Blondon J, et al. Primary chemotherapy and preoperative irradiation for patients with Stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol. 1997;42:219-229.
22. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of Stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988;62:2507-2516.
23. Haagensen C, Stout A. Carcinoma of the breast: criteria of inoperability. Am Surg. 1943;118:859-866.
24. Haagensen C. Clinical classification of the stage of advancement of breast carcinoma. Diseases of the breast, 3rd ed. Philadelphia: WB Saunders Company, 1986:851-863.
25. Witherspoon L. Discussion on "Management of women who present with T4 breast cancer" by GV Poole et al. Am Surg. 2004;70:666-667.
26. McCarty K, Nath M. Breast: lymphatic drainage. In: Sternberg S, editor. Histology for pathologists, 2nd ed. Philadelphia: Lippincott-Raven, 1997:76.
27. Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001;192:399-409.
28. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119-1126.
29. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Little-Johns P, Richards MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999;353:1127-1131.
30. Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol. 2003;21:2254-2259.